PCLX-001 is an orally acitve, small-molecule, dual N-myristoyltransferase (NMT) inhibitor, with IC50s of 5 nM (NMT1) and 8 nM (NMT2), respectively. PCLX-001 exhibits anti-tumor activity and inhibits early B-cell receptor (BCR) signaling, can be used to B-cell malignancies research.
Molecular Weight:
537.51
Purity:
99.0%
CAS Number:
[1215011-08-7]
Formula:
C24H30Cl2N6O2S
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted